Amie Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amie Wilson has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Malalana
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool Neston UK
3 shared publications Alison Talbot
Department of Equine Clinical Science, Institute of Veterinary and Ecological Sciences University of Liverpool Liverpool UK
2 shared publications- Catherine Marie McGowan
University of Liverpool image/svg+xml
2 shared publications Gina Pinchbeck
Department of Equine Clinical Science, Institute of Veterinary and Ecological Sciences University of Liverpool Neston UK
2 shared publications- Christopher M. Baldwin
Department of Equine Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK
1 shared publication Emanuele Ricci
Department of Veterinary Anatomy, Physiology and Pathology, Institute of Veterinary and Ecological Sciences University of Liverpool Liverpool UK
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by Wiley in Equine Veterinary Education
- Vol. 38 (3)
Distal urethral obstruction in an eight‐week‐old colt with struvite urolithiasis
Summary: An 8‐week‐old Thoroughbred colt presented with acute colic signs. Physical examination and transcutaneous ultrasound of the abdomen and penis revealed a urinary tract obstruction in the distal urethra due to urolithiasis. A distal urethrotomy over the site of obstruction was performed to remove the urolith and relieve the obstruction. Analysis of urolith constituency revealed the presence of pure magnesium ammonium phosphate hexahydrate (struvite). Urinalysis identified a lower urinary tract infection (UTI) with the presence of urease‐producing bacteria. Patent urinary flow via the urinary catheter was present immediately after surgery. Urinary catheterisation was discontinued after 36 h, and the foal resumed normal micturition. The foal was discharged after 5 days. At telephone follow‐up 12 months later, the owner reported no recurrence of urolithiasis or altered micturition. At the time of authorship, this report describes the youngest case of urolithiasis in equids documented in the literature and features an atypical crystalloid composition of the urolith. The report highlights the potential for urolith development in young foals with concurrent lower UTI and urethral obstruction as a differential for colic in foals.
- 18 December 2025
- Published by Wiley in Equine Veterinary Education
- Vol. 38 (3)
Open AccessDistal urethral obstruction in an eight‐week‐old colt with struvite urolithiasis
Summary: An 8‐week‐old Thoroughbred colt presented with acute colic signs. Physical examination and transcutaneous ultrasound of the abdomen and penis revealed a urinary tract obstruction in the distal urethra due to urolithiasis. A distal urethrotomy over the site of obstruction was performed to remove the urolith and relieve the obstruction. Analysis of urolith constituency revealed the presence of pure magnesium ammonium phosphate hexahydrate (struvite). Urinalysis identified a lower urinary tract infection (UTI) with the presence of urease‐producing bacteria. Patent urinary flow via the urinary catheter was present immediately after surgery. Urinary catheterisation was discontinued after 36 h, and the foal resumed normal micturition. The foal was discharged after 5 days. At telephone follow‐up 12 months later, the owner reported no recurrence of urolithiasis or altered micturition. At the time of authorship, this report describes the youngest case of urolithiasis in equids documented in the literature and features an atypical crystalloid composition of the urolith. The report highlights the potential for urolith development in young foals with concurrent lower UTI and urethral obstruction as a differential for colic in foals.
- Open Access
- 3 July 2023
- Published by Wiley in Equine Veterinary Education
- Vol. 36 (3) , E67-E72
Suspected idiopathic vestibular syndrome in the horse: Eight cases (2014–2021)
Summary: A descriptive case series of the presentation, diagnosis, treatment and outcome of eight horses presenting to a UK equine veterinary hospital with suspected idiopathic peripheral vestibular syndrome over a 7‐year period (2014–2021). Idiopathic vestibular syndrome in the horse causes unilateral clinical signs including; ataxia, nystagmus, strabismus and a head tilt. Diagnosis is aided by neurological examination, endoscopy of the upper airway and cross‐sectional imaging (i.e. magnetic resonance imaging and computed tomography). This case series indicates that horses with this condition can make a full recovery with return to ridden exercise. Treatment with anti‐inflammatory medication did not appear to influence outcome.
- 3 July 2023
- Published by Wiley in Equine Veterinary Education
- Vol. 36 (3) , E67-E72
Open AccessSuspected idiopathic vestibular syndrome in the horse: Eight cases (2014–2021)
Summary: A descriptive case series of the presentation, diagnosis, treatment and outcome of eight horses presenting to a UK equine veterinary hospital with suspected idiopathic peripheral vestibular syndrome over a 7‐year period (2014–2021). Idiopathic vestibular syndrome in the horse causes unilateral clinical signs including; ataxia, nystagmus, strabismus and a head tilt. Diagnosis is aided by neurological examination, endoscopy of the upper airway and cross‐sectional imaging (i.e. magnetic resonance imaging and computed tomography). This case series indicates that horses with this condition can make a full recovery with return to ridden exercise. Treatment with anti‐inflammatory medication did not appear to influence outcome.
- Open Access
- 30 November 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (6) , E451-E456
Invasive squamous cell carcinoma causes trigeminal nerve dysfunction in a horse
Summary: A 12‐year‐old Irish Sports Horse gelding was presented for investigation of a 4‐month history of recurrent right sided corneal ulceration and sudden onset dysphagia and inappetence. Cranial nerve examination revealed dysfunction of the right oculomotor nerve and trigeminal nerve. Computed tomography of the skull demonstrated a mass in the region of the orbital fissure, in close association with the oculomotor and trigeminal nerves. Following the assessment, the gelding was euthanised and post‐mortem examination was performed. Histopathology of the mass confirmed that the tumour was a squamous cell carcinoma. This case report highlights the benefits of detailed clinical examination to localise a neurological lesion, and the need for histology to confirm the diagnosis.
- 30 November 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (6) , E451-E456
Open AccessInvasive squamous cell carcinoma causes trigeminal nerve dysfunction in a horse
Summary: A 12‐year‐old Irish Sports Horse gelding was presented for investigation of a 4‐month history of recurrent right sided corneal ulceration and sudden onset dysphagia and inappetence. Cranial nerve examination revealed dysfunction of the right oculomotor nerve and trigeminal nerve. Computed tomography of the skull demonstrated a mass in the region of the orbital fissure, in close association with the oculomotor and trigeminal nerves. Following the assessment, the gelding was euthanised and post‐mortem examination was performed. Histopathology of the mass confirmed that the tumour was a squamous cell carcinoma. This case report highlights the benefits of detailed clinical examination to localise a neurological lesion, and the need for histology to confirm the diagnosis.
- Open Access
- 9 November 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (6) , 300-304
Masseter myodegeneration in the horse: Suggested approach to diagnosis and treatment
Summary: A descriptive case report of the management of a miniature pony presenting to a UK equine veterinary hospital with marked trismus and increased masseter muscle size. Diagnosis of masseter myodegeneration (MM) was aided by the use of computed tomography and excisional biopsy. Hyperlipaemia was diagnosed as a sequelae of MM. Treatment included nonsteroidal anti‐inflammatories, parenteral nutrition and fluid therapy in addition to supportive care. The gelding was discharged from the hospital 30 days after admission, having made a full recovery. MM in the horse is a rare condition that appears to be physiologically distinct from canine masticatory muscle myositis which is primarily immune mediated.
- 9 November 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (6) , 300-304
Open AccessMasseter myodegeneration in the horse: Suggested approach to diagnosis and treatment
Summary: A descriptive case report of the management of a miniature pony presenting to a UK equine veterinary hospital with marked trismus and increased masseter muscle size. Diagnosis of masseter myodegeneration (MM) was aided by the use of computed tomography and excisional biopsy. Hyperlipaemia was diagnosed as a sequelae of MM. Treatment included nonsteroidal anti‐inflammatories, parenteral nutrition and fluid therapy in addition to supportive care. The gelding was discharged from the hospital 30 days after admission, having made a full recovery. MM in the horse is a rare condition that appears to be physiologically distinct from canine masticatory muscle myositis which is primarily immune mediated.
- Open Access
- 19 June 2022
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (3) , 494-505
Antimicrobial prescribing and antimicrobial resistance surveillance in equine practice
Background: Antimicrobial resistance (AMR) is an increasingly serious threat to human and animal health, therefore responsible use of antimicrobials in equine practice is vital. There is a need to have accurate, up to date data on antimicrobial prescribing in equine practice in the UK.Objectives: To characterise current antimicrobial prescribing practices by equine veterinarians and to describe surveillance, audit processes and identification of AMR.Study design: Online cross‐sectional, questionnaire‐based survey.Methods: An online questionnaire targeting veterinarians who treat horses in the UK and Europe was distributed. The questionnaire collected data on participants' country of origin, practice policies, prescribing practices including use of high priority critical antimicrobials. Four common clinical case‐based scenarios were included to further explore prescribing practice. Responses were compared using both descriptive statistics and multivariable logistic regression models.Results: Questionnaires were completed by 264 veterinarians from Europe (n = 33/264) and the UK (n = 231/264); 87% respondents worked only with horses and 67% worked at premises with hospitalisation facilities. Approximately half of respondents (54.4%) had a written antimicrobial use or stewardship policy within their practice. Over half of respondents did not perform any environmental surveillance (54.2%), audit of clinical infections (53.1%) or audit of infection control (57.1%). Potentiated sulphonamides were cited as the most used antimicrobial, although 44% reported using enrofloxacin in the last year and 66% used 3rd or 4th generation cephalosporins. Prophylactic antimicrobials before clean surgery were frequently/always prescribed by 48% respondents and 24% respondents frequently/always prescribed antimicrobials post‐operatively in clean surgery.Main limitations: Potential selection bias of respondents, given individuals volunteered to take part in the survey.Conclusions: Compared with a previous similar study conducted in 2009, overall antimicrobial usage appeared to be declining in clinical scenarios and a greater proportion of practices now have stewardship policies. However, the use of high priority critical antimicrobials is still relatively common in equine practice in the UK and Europe.
- 19 June 2022
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (3) , 494-505
Open AccessAntimicrobial prescribing and antimicrobial resistance surveillance in equine practice
Background: Antimicrobial resistance (AMR) is an increasingly serious threat to human and animal health, therefore responsible use of antimicrobials in equine practice is vital. There is a need to have accurate, up to date data on antimicrobial prescribing in equine practice in the UK.Objectives: To characterise current antimicrobial prescribing practices by equine veterinarians and to describe surveillance, audit processes and identification of AMR.Study design: Online cross‐sectional, questionnaire‐based survey.Methods: An online questionnaire targeting veterinarians who treat horses in the UK and Europe was distributed. The questionnaire collected data on participants' country of origin, practice policies, prescribing practices including use of high priority critical antimicrobials. Four common clinical case‐based scenarios were included to further explore prescribing practice. Responses were compared using both descriptive statistics and multivariable logistic regression models.Results: Questionnaires were completed by 264 veterinarians from Europe (n = 33/264) and the UK (n = 231/264); 87% respondents worked only with horses and 67% worked at premises with hospitalisation facilities. Approximately half of respondents (54.4%) had a written antimicrobial use or stewardship policy within their practice. Over half of respondents did not perform any environmental surveillance (54.2%), audit of clinical infections (53.1%) or audit of infection control (57.1%). Potentiated sulphonamides were cited as the most used antimicrobial, although 44% reported using enrofloxacin in the last year and 66% used 3rd or 4th generation cephalosporins. Prophylactic antimicrobials before clean surgery were frequently/always prescribed by 48% respondents and 24% respondents frequently/always prescribed antimicrobials post‐operatively in clean surgery.Main limitations: Potential selection bias of respondents, given individuals volunteered to take part in the survey.Conclusions: Compared with a previous similar study conducted in 2009, overall antimicrobial usage appeared to be declining in clinical scenarios and a greater proportion of practices now have stewardship policies. However, the use of high priority critical antimicrobials is still relatively common in equine practice in the UK and Europe.
- Open Access
- 30 October 2020
- Published by Wiley in Equine Veterinary Journal
- Vol. 53 (5) , 1004-1014
Equine influenza vaccination in the UK: Current practices may leave horses with suboptimal immunity
Background: Vaccination is integral to preventive healthcare. Despite numerous guidelines on equine vaccination, evidence of current vaccination practices is lacking.Objectives: To describe current vaccination practices advised by vets treating horses in the United Kingdom (UK) and compare practices with manufacturer datasheets and current guidelines.Study design: Cross‐sectional survey.Methods: An online questionnaire was distributed using email addresses acquired through professional registration listings and social media, targeting vets who treat horses in the UK. The questionnaire collected demographic data and information regarding vaccination practices and vaccine hesitancy. Descriptive statistical analysis was performed.Results: Questionnaires were completed by 304 UK vets working with horses used for leisure (97.4%, n = 296/304), competition (86.2%, n = 262/304), stud‐work (47.7%, n = 145/304) and racing (40.5%, n = 123/304). Variation was identified in vaccine protocols for competition and noncompetition horses. Fifty‐seven per cent (n = 170/298) of respondents reported variation in advised ‘booster’ frequency; most commonly (n = 118) advising a 6‐monthly vaccination in competition horses and annual vaccination in noncompetition horses. Most common vaccination guidelines volunteered were British Horseracing Authority (68.8%, n = 172/250) and Federation Equestre Internationale (66.4%, n = 166/250). Most vaccination practices were not consistent with datasheet guidance. Only 7.7% (n = 23/300) of respondents complied with datasheet timeframes between the second and third vaccination. Adverse events following vaccination in the previous year were encountered by 66% (n = 199/304) of respondents, representing 2760 adverse events; but only 526 (19.1%) cases were reported to the Veterinary Medicines Directorate. Most common reactions were transient, including stiffness (931), localised swelling (835), lethargy (559) and pyrexia (355). 86.4% respondents reported vaccine hesitancy from horse owners, most commonly due to perception of over‐vaccination, cost and concern regarding adverse events.Main limitations: Potential selection, respondent and recall bias. The recent Equine Influenza (EI) and Equine Herpes Virus (EHV) outbreaks in the UK may have altered responses.Conclusions: Current equine vaccination practices, although complying with competition rules, are mostly noncompliant with datasheet guidelines, potentially risking suboptimal immunity.
- 30 October 2020
- Published by Wiley in Equine Veterinary Journal
- Vol. 53 (5) , 1004-1014
Open AccessEquine influenza vaccination in the UK: Current practices may leave horses with suboptimal immunity
Background: Vaccination is integral to preventive healthcare. Despite numerous guidelines on equine vaccination, evidence of current vaccination practices is lacking.Objectives: To describe current vaccination practices advised by vets treating horses in the United Kingdom (UK) and compare practices with manufacturer datasheets and current guidelines.Study design: Cross‐sectional survey.Methods: An online questionnaire was distributed using email addresses acquired through professional registration listings and social media, targeting vets who treat horses in the UK. The questionnaire collected demographic data and information regarding vaccination practices and vaccine hesitancy. Descriptive statistical analysis was performed.Results: Questionnaires were completed by 304 UK vets working with horses used for leisure (97.4%, n = 296/304), competition (86.2%, n = 262/304), stud‐work (47.7%, n = 145/304) and racing (40.5%, n = 123/304). Variation was identified in vaccine protocols for competition and noncompetition horses. Fifty‐seven per cent (n = 170/298) of respondents reported variation in advised ‘booster’ frequency; most commonly (n = 118) advising a 6‐monthly vaccination in competition horses and annual vaccination in noncompetition horses. Most common vaccination guidelines volunteered were British Horseracing Authority (68.8%, n = 172/250) and Federation Equestre Internationale (66.4%, n = 166/250). Most vaccination practices were not consistent with datasheet guidance. Only 7.7% (n = 23/300) of respondents complied with datasheet timeframes between the second and third vaccination. Adverse events following vaccination in the previous year were encountered by 66% (n = 199/304) of respondents, representing 2760 adverse events; but only 526 (19.1%) cases were reported to the Veterinary Medicines Directorate. Most common reactions were transient, including stiffness (931), localised swelling (835), lethargy (559) and pyrexia (355). 86.4% respondents reported vaccine hesitancy from horse owners, most commonly due to perception of over‐vaccination, cost and concern regarding adverse events.Main limitations: Potential selection, respondent and recall bias. The recent Equine Influenza (EI) and Equine Herpes Virus (EHV) outbreaks in the UK may have altered responses.Conclusions: Current equine vaccination practices, although complying with competition rules, are mostly noncompliant with datasheet guidelines, potentially risking suboptimal immunity.